Neo-adjuvant/adjuvant treatment in gastric cancer
Neo-adjuvant/adjuvant treatment in gastric cancer
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Implementation of a wait and see program for rectal cancer
Cholangiocarcinoma and gallbladder cancer
Left versus right in colon cancer
The GI oncologist of the future
Minimally invasive surgery for cancer of the oesophagus
Acquired resistance to EGFR antibodies
Low-value practices in oncology contributing to financial toxicity
The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches
WIN 2017 conference review